About MedtronicMedtronic, headquartered in Minneapolis, is the global leader in medical technology – alleviating pain, restoring health, and extending life for millions of people around the world.
Medtronic has been an innovator and leader in the field the endovascular stent graft industry for over a decade more implants more implants than any other company. Its long history includes more than 100,000 patients with aortic stent grafts of 1995 handled. Medtronic currently offers the broadest portfolio of endovascular stent graft in the industry. These include the AneuRx AAdvantage Abdominal Stent Graft System in the United States, and the Talent Abdominal, Talent Thoracic and Valiant Thoracic Stent Graft Systems outside the United States.Researchers achieved either order the Side effects from radiation and order to reduce stopping treatment to reduce, with radiotherapy, treatment therapy. The highly toxic treatment ofOver 70 percent of oral and pharyngeal cancers treated with surgery occasion need further treatment with radiotherapy, chemotherapy due to the significant risks for the recurrence and the spread by the nodes. Radiotherapy plus chemotherapy are highly poisonous, mainly because of the ulcer of the mucous membrane of the mouth; toxicity Jun lead patients to the treatment, which significantly reduces stop a chances of recovery..
After three years follow-up, with the new technology achieves scientists volume of the irradiated tissue to 44 percent of patients reduced. This new technology was avoided irradiation having an average volume of 118 cc of tissue. Overall, 95 percent of patients completed at radiotherapy and presented to much lower toxicity than patients dealt to the traditional technology. Recurrence rates of not increase.
The new log provides a less invasive but equally effective cancer postoperative management of cancers of the oral cavity and pharynx.